{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:51:17Z","timestamp":1792792277742,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T00:00:00Z","timestamp":1440806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T00:00:00Z","timestamp":1440806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Zellweger spectrum disorder (PBD-ZSD) is a disease continuum caused by mutations in a subset of<jats:italic>PEX<\/jats:italic>genes required for normal peroxisome assembly and function. They highlight the importance of peroxisomes in the development and functions of the central nervous system, liver, and other organs. To date, the underlying bases for the cell-type specificity of disease are not fully elucidated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Primary skin fibroblasts from seven PBD-ZSD patients with biallelic<jats:italic>PEX1<\/jats:italic>,<jats:italic>PEX10<\/jats:italic>,<jats:italic>PEX12<\/jats:italic>, or<jats:italic>PEX26<\/jats:italic>mutations and three healthy donors were transduced with retroviral vectors expressing Yamanaka reprogramming factors. Candidate induced pluripotent stem cells (iPSCs) were subject to global gene expression, DNA methylation, copy number variation, genotyping, in vitro differentiation and teratoma formation assays. Confirmed iPSCs were differentiated into neural progenitor cells (NPCs), neurons, oligodendrocyte precursor cells (OPCs), and hepatocyte-like cell cultures with peroxisome assembly evaluated by microscopy. Saturated very long chain fatty acid (sVLCFA) and plasmalogen levels were determined in primary fibroblasts and their derivatives.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>iPSCs were derived from seven PBD-ZSD patient-derived fibroblasts with mild to severe peroxisome assembly defects. Although patient and control skin fibroblasts had similar gene expression profiles, genes related to mitochondrial functions and organelle cross-talk were differentially expressed among corresponding iPSCs. Mitochondrial DNA levels were consistent among patient and control fibroblasts, but varied among all iPSCs. Relative to matching controls, sVLCFA levels were elevated in patient-derived fibroblasts, reduced in patient-derived iPSCs, and not significantly different in patient-derived NPCs. All cell types derived from donors with biallelic null mutations in a<jats:italic>PEX<\/jats:italic>gene showed plasmalogen deficiencies. Reporter gene assays compatible with high content screening (HCS) indicated patient-derived OPC and hepatocyte-like cell cultures had impaired peroxisome assembly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Normal peroxisome activity levels are not required for cellular reprogramming of skin fibroblasts. Patient iPSC gene expression profiles were consistent with hypotheses highlighting the role of altered mitochondrial activities and organelle cross-talk in PBD-ZSD pathogenesis. sVLCFA abnormalities dramatically differed among patient cell types, similar to observations made in iPSC models of X-linked adrenoleukodystrophy. We propose that iPSCs could assist investigations into the cell type-specificity of peroxisomal activities, toxicology studies, and in HCS for targeted therapies for peroxisome-related disorders.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13287-015-0149-3","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T16:33:51Z","timestamp":1440779631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities"],"prefix":"10.1186","volume":"6","author":[{"given":"Xiao-Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Yan","family":"Yik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wange","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Ram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Zitting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann B.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Hacia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,29]]},"reference":[{"key":"149_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrm3700","volume":"14","author":"JJ Smith","year":"2013","unstructured":"Smith JJ, Aitchison JD. Peroxisomes take shape. Nat Rev Mol Cell Biol. 2013;14:803\u201317.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"149_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biochi.2013.08.022","volume":"98","author":"RJ Wanders","year":"2014","unstructured":"Wanders RJ. Metabolic functions of peroxisomes in health and disease. Biochimie. 2014;98:36\u201344.","journal-title":"Biochimie"},{"key":"149_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbamcr.2010.03.013","volume":"1803","author":"M Islinger","year":"2010","unstructured":"Islinger M, Cardoso MJ, Schrader M. Be different\u2014the diversity of peroxisomes in the animal kingdom. Biochim Biophys Acta. 2010;1803:881\u201397.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR4","doi-asserted-by":"publisher","first-page":"bas062","DOI":"10.1093\/database\/bas062","volume":"2013","author":"P Mutowo-Meullenet","year":"2013","unstructured":"Mutowo-Meullenet P, Huntley RP, Dimmer EC, Alam-Faruque Y, Sawford T, Jesus Martin M, et al. Use of Gene Ontology Annotation to understand the peroxisome proteome in humans. Database (Oxford). 2013;2013:bas062.","journal-title":"Database (Oxford)"},{"key":"149_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057395","volume":"8","author":"T Gronemeyer","year":"2013","unstructured":"Gronemeyer T, Wiese S, Ofman R, Bunse C, Pawlas M, Hayen H, et al. The proteome of human liver peroxisomes: identification of five new peroxisomal constituents by a label-free quantitative proteomics survey. PLoS One. 2013;8:e57395.","journal-title":"PLoS One"},{"key":"149_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.biochem.74.082803.133329","volume":"75","author":"RJ Wanders","year":"2006","unstructured":"Wanders RJ, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem. 2006;75:295\u2013332.","journal-title":"Annu Rev Biochem"},{"key":"149_CR7","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","volume":"1822","author":"NE Braverman","year":"2012","unstructured":"Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 2012;1822:1442\u201352.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.bbadis.2012.05.014","volume":"1822","author":"TF da Silva","year":"2012","unstructured":"da Silva TF, Sousa VF, Malheiro AR, Brites P. The importance of ether-phospholipids: a view from the perspective of mouse models. Biochim Biophys Acta. 2012;1822:1501\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR9","unstructured":"Steinberg SJ, Raymond GV, Braverman NE, Moser AB. Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT et al., editors. GeneReviews(R). Seattle (WA)1993."},{"key":"149_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10545-007-0516-z","volume":"30","author":"N Shimozawa","year":"2007","unstructured":"Shimozawa N. Molecular and clinical aspects of peroxisomal diseases. J Inherit Metab Dis. 2007;30:193\u20137.","journal-title":"J Inherit Metab Dis"},{"key":"149_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ddrr.1113","volume":"17","author":"NE Braverman","year":"2013","unstructured":"Braverman NE, D\u2019Agostino MD, Maclean GE. Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives. Dev Disabil Res Rev. 2013;17:187\u201396.","journal-title":"Dev Disabil Res Rev"},{"key":"149_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2014.02.007","volume":"69","author":"DI Crane","year":"2014","unstructured":"Crane DI. Revisiting the neuropathogenesis of Zellweger syndrome. Neurochem Int. 2014;69:1\u20138.","journal-title":"Neurochem Int"},{"key":"149_CR13","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1212\/WNL.0b013e3182929f8e","volume":"80","author":"PR Lee","year":"2013","unstructured":"Lee PR, Raymond GV. Child neurology: Zellweger syndrome. Neurology. 2013;80:e207\u201310.","journal-title":"Neurology"},{"key":"149_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ajmg.a.20664","volume":"126A","author":"BT Poll-The","year":"2004","unstructured":"Poll-The BT, Gootjes J, Duran M, De Klerk JB, Wenniger-Prick LJ, Admiraal RJ, et al. Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients. Am J Med Genet A. 2004;126A:333\u20138.","journal-title":"Am J Med Genet A"},{"key":"149_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/jmedgenet-2011-100288","volume":"48","author":"J Majewski","year":"2011","unstructured":"Majewski J, Wang Z, Lopez I, Al Humaid S, Ren H, Racine J, et al. A new ocular phenotype associated with an unexpected but known systemic disorder and mutation: novel use of genomic diagnostics and exome sequencing. J Med Genet. 2011;48:593\u20136.","journal-title":"J Med Genet"},{"key":"149_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/321265","volume":"69","author":"C Walter","year":"2001","unstructured":"Walter C, Gootjes J, Mooijer PA, Portsteffen H, Klein C, Waterham HR, et al. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Am J Hum Genet. 2001;69:35\u201348.","journal-title":"Am J Hum Genet"},{"key":"149_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ejhg.2008.252","volume":"17","author":"C Krause","year":"2009","unstructured":"Krause C, Rosewich H, Gartner J. Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur J Hum Genet. 2009;17:741\u20138.","journal-title":"Eur J Hum Genet"},{"key":"149_CR18","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1073\/pnas.0914960107","volume":"107","author":"R Zhang","year":"2010","unstructured":"Zhang R, Chen L, Jiralerspong S, Snowden A, Steinberg S, Braverman N. Recovery of PEX1-Gly843Asp peroxisome dysfunction by small-molecule compounds. Proc Natl Acad Sci U S A. 2010;107:5569\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"149_CR19","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1101\/gr.1289803","volume":"13","author":"MW Karaman","year":"2003","unstructured":"Karaman MW, Houck ML, Chemnick LG, Nagpal S, Chawannakul D, Sudano D, et al. Comparative analysis of gene-expression patterns in human and African great ape cultured fibroblasts. Genome Res. 2003;13:1619\u201330.","journal-title":"Genome Res"},{"key":"149_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/scrt130","volume":"3","author":"XM Wang","year":"2012","unstructured":"Wang XM, Yik WY, Zhang P, Lu W, Dranchak PK, Shibata D, et al. The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis. Stem Cell Res Ther. 2012;3:39.","journal-title":"Stem Cell Res Ther"},{"key":"149_CR21","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nprot.2008.92","volume":"3","author":"IH Park","year":"2008","unstructured":"Park IH, Lerou PH, Zhao R, Huo H, Daley GQ. Generation of human-induced pluripotent stem cells. Nat Protoc. 2008;3:1180\u20136.","journal-title":"Nat Protoc"},{"key":"149_CR22","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1038\/nprot.2007.418","volume":"2","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2007;2:3081\u20139.","journal-title":"Nat Protoc"},{"key":"149_CR23","doi-asserted-by":"publisher","first-page":"pdb prot5260","DOI":"10.1101\/pdb.prot5260","volume":"2009","author":"Y Wang","year":"2009","unstructured":"Wang Y, McClelland M, Xia XQ. Analyzing microarray data using WebArray. Cold Spring Harb Protoc. 2009;2009:pdb prot5260.","journal-title":"Cold Spring Harb Protoc"},{"key":"149_CR24","doi-asserted-by":"publisher","first-page":"W77","DOI":"10.1093\/nar\/gkt439","volume":"41","author":"J Wang","year":"2013","unstructured":"Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013;41:W77\u201383.","journal-title":"Nucleic Acids Res"},{"key":"149_CR25","unstructured":"National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) repository. http:\/\/www.ncbi.nlm.nih.gov\/geo\/."},{"key":"149_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.stem.2010.12.003","volume":"8","author":"LC Laurent","year":"2011","unstructured":"Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011;8:106\u201318.","journal-title":"Cell Stem Cell"},{"key":"149_CR27","doi-asserted-by":"publisher","first-page":"E467","DOI":"10.1002\/humu.20932","volume":"30","author":"WY Yik","year":"2009","unstructured":"Yik WY, Steinberg SJ, Moser AB, Moser HW, Hacia JG. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders. Hum Mutat. 2009;30:E467\u201380.","journal-title":"Hum Mutat"},{"key":"149_CR28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/leu.2008.18","volume":"22","author":"BL Pike","year":"2008","unstructured":"Pike BL, Greiner TC, Wang X, Weisenburger DD, Hsu YH, Renaud G, et al. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia. 2008;22:1035\u201343.","journal-title":"Leukemia"},{"key":"149_CR29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jcb.22461","volume":"109","author":"XM Wang","year":"2010","unstructured":"Wang XM, Greiner TC, Bibikova M, Pike BL, Siegmund KD, Sinha UK, et al. Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations. J Cell Biochem. 2010;109:818\u201327.","journal-title":"J Cell Biochem"},{"key":"149_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/1471-2164-9-521","volume":"9","author":"D Magda","year":"2008","unstructured":"Magda D, Lecane P, Prescott J, Thiemann P, Ma X, Dranchak PK, et al. mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft. BMC Genomics. 2008;9:521.","journal-title":"BMC Genomics"},{"key":"149_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jasms.2004.07.009","volume":"15","author":"KA Zemski Berry","year":"2004","unstructured":"Zemski Berry KA, Murphy RC. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J Am Soc Mass Spectrom. 2004;15:1499\u2013508.","journal-title":"J Am Soc Mass Spectrom"},{"key":"149_CR32","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2009.127","volume":"4","author":"BY Hu","year":"2009","unstructured":"Hu BY, Zhang SC. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc. 2009;4:1295\u2013304.","journal-title":"Nat Protoc"},{"key":"149_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-60327-931-4_4","volume":"549","author":"X Xia","year":"2009","unstructured":"Xia X, Zhang SC. Differentiation of neuroepithelia from human embryonic stem cells. Methods Mol Biol. 2009;549:51\u20138.","journal-title":"Methods Mol Biol"},{"key":"149_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/glia.20127","volume":"49","author":"GI Nistor","year":"2005","unstructured":"Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005;49:385\u201396.","journal-title":"Glia"},{"key":"149_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mcn.2005.10.014","volume":"31","author":"PL Zhang","year":"2006","unstructured":"Zhang PL, Izrael M, Ainbinder E, Ben-Simchon L, Chebath J, Revel M. Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6\/soluble interleukin-6 receptor fusion protein. Mol Cell Neurosci. 2006;31:387\u201398.","journal-title":"Mol Cell Neurosci"},{"key":"149_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.mcn.2006.11.008","volume":"34","author":"M Izrael","year":"2007","unstructured":"Izrael M, Zhang P, Kaufman R, Shinder V, Ella R, Amit M, et al. Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci. 2007;34:310\u201323.","journal-title":"Mol Cell Neurosci"},{"key":"149_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-60327-931-4_5","volume":"549","author":"MN Hatch","year":"2009","unstructured":"Hatch MN, Nistor G, Keirstead HS. Derivation of high-purity oligodendroglial progenitors. Methods Mol Biol. 2009;549:59\u201375.","journal-title":"Methods Mol Biol"},{"key":"149_CR38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/stem.245","volume":"28","author":"J Sharp","year":"2010","unstructured":"Sharp J, Frame J, Siegenthaler M, Nistor G, Keirstead HS. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells. 2010;28:152\u201363.","journal-title":"Stem Cells"},{"key":"149_CR39","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1634\/stemcells.2007-0291","volume":"25","author":"Y Duan","year":"2007","unstructured":"Duan Y, Catana A, Meng Y, Yamamoto N, He S, Gupta S, et al. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells. 2007;25:3058\u201368.","journal-title":"Stem Cells"},{"key":"149_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/stem.315","volume":"28","author":"Y Duan","year":"2010","unstructured":"Duan Y, Ma X, Zou W, Wang C, Bahbahan IS, Ahuja TP, et al. Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells. 2010;28:674\u201386.","journal-title":"Stem Cells"},{"key":"149_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature09871","volume":"471","author":"SM Hussein","year":"2011","unstructured":"Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011;471:58\u201362.","journal-title":"Nature"},{"key":"149_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nbt.1835","volume":"29","author":"SM Taapken","year":"2011","unstructured":"Taapken SM, Nisler BS, Newton MA, Sampsell-Barron TL, Leonhard KA, McIntire EM, et al. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol. 2011;29:313\u20134.","journal-title":"Nat Biotechnol"},{"key":"149_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nbt.1890","volume":"29","author":"K Martins-Taylor","year":"2011","unstructured":"Martins-Taylor K, Nisler BS, Taapken SM, Compton T, Crandall L, Montgomery KD, et al. Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol. 2011;29:488\u201391.","journal-title":"Nat Biotechnol"},{"key":"149_CR44","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1073\/pnas.0711983105","volume":"105","author":"WE Lowry","year":"2008","unstructured":"Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 2008;105:2883\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"149_CR45","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1111\/j.1742-4658.2010.07741.x","volume":"277","author":"M Oku","year":"2010","unstructured":"Oku M, Sakai Y. Peroxisomes as dynamic organelles: autophagic degradation. FEBS J. 2010;277:3289\u201394.","journal-title":"FEBS J"},{"key":"149_CR46","doi-asserted-by":"publisher","first-page":"17711","DOI":"10.1073\/pnas.0904762106","volume":"106","author":"N Kanzawa","year":"2009","unstructured":"Kanzawa N, Maeda Y, Ogiso H, Murakami Y, Taguchi R, Kinoshita T. Peroxisome dependency of alkyl-containing GPI-anchor biosynthesis in the endoplasmic reticulum. Proc Natl Acad Sci U S A. 2009;106:17711\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"149_CR47","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1194\/jlr.M021204","volume":"53","author":"N Kanzawa","year":"2012","unstructured":"Kanzawa N, Shimozawa N, Wanders RJ, Ikeda K, Murakami Y, Waterham HR, et al. Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata. J Lipid Res. 2012;53:653\u201363.","journal-title":"J Lipid Res"},{"key":"149_CR48","doi-asserted-by":"publisher","first-page":"20763","DOI":"10.1074\/jbc.M611853200","volume":"282","author":"B Ashibe","year":"2007","unstructured":"Ashibe B, Hirai T, Higashi K, Sekimizu K, Motojima K. Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing. J Biol Chem. 2007;282:20763\u201373.","journal-title":"J Biol Chem"},{"key":"149_CR49","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ng2070","volume":"39","author":"CM Kassmann","year":"2007","unstructured":"Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, Werner HB, et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet. 2007;39:969\u201376.","journal-title":"Nat Genet"},{"key":"149_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1073858409336297","volume":"15","author":"M Baes","year":"2009","unstructured":"Baes M, Aubourg P. Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist. 2009;15:367\u201379.","journal-title":"Neuroscientist"},{"key":"149_CR51","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.bbamcr.2006.09.010","volume":"1763","author":"SJ Steinberg","year":"2006","unstructured":"Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW. Peroxisome biogenesis disorders. Biochim Biophys Acta. 2006;1763:1733\u201348.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR52","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/hmg\/7.13.2089","volume":"7","author":"A Imamura","year":"1998","unstructured":"Imamura A, Tamura S, Shimozawa N, Suzuki Y, Zhang Z, Tsukamoto T, et al. Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders. Hum Mol Genet. 1998;7:2089\u201394.","journal-title":"Hum Mol Genet"},{"key":"149_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10545-008-0969-8","volume":"32","author":"SJ Steinberg","year":"2009","unstructured":"Steinberg SJ, Snowden A, Braverman NE, Chen L, Watkins PA, Clayton PT, et al. A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. J Inherit Metab Dis. 2009;32:109\u201319.","journal-title":"J Inherit Metab Dis"},{"key":"149_CR54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/humu.20062","volume":"24","author":"J Gootjes","year":"2004","unstructured":"Gootjes J, Schmohl F, Mooijer PA, Dekker C, Mandel H, Topcu M, et al. Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40 degrees C: implications for other inborn errors of metabolism. Hum Mutat. 2004;24:130\u20139.","journal-title":"Hum Mutat"},{"key":"149_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1086\/377004","volume":"73","author":"N Matsumoto","year":"2003","unstructured":"Matsumoto N, Tamura S, Furuki S, Miyata N, Moser A, Shimozawa N, et al. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. Am J Hum Genet. 2003;73:233\u201346.","journal-title":"Am J Hum Genet"},{"key":"149_CR56","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1172\/JCI0215182","volume":"109","author":"RE Schwartz","year":"2002","unstructured":"Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109:1291\u2013302.","journal-title":"J Clin Invest"},{"key":"149_CR57","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.bbadis.2012.04.006","volume":"1822","author":"HR Waterham","year":"2012","unstructured":"Waterham HR, Ebberink MS. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta. 2012;1822:1430\u201341.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR58","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/B978-0-444-59565-2.00028-9","volume":"113","author":"P Aubourg","year":"2013","unstructured":"Aubourg P, Wanders R. Peroxisomal disorders. Handb Clin Neurol. 2013;113:1593\u2013609.","journal-title":"Handb Clin Neurol"},{"key":"149_CR59","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.bbadis.2012.06.004","volume":"1822","author":"Y Fujiki","year":"2012","unstructured":"Fujiki Y, Yagita Y, Matsuzaki T. Peroxisome biogenesis disorders: molecular basis for impaired peroxisomal membrane assembly: in metabolic functions and biogenesis of peroxisomes in health and disease. Biochim Biophys Acta. 2012;1822:1337\u201342.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR60","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s10545-008-0856-3","volume":"31","author":"S Weller","year":"2008","unstructured":"Weller S, Rosewich H, Gartner J. Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients. J Inherit Metab Dis. 2008;31:270\u201380.","journal-title":"J Inherit Metab Dis"},{"key":"149_CR61","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.biocel.2013.06.019","volume":"45","author":"DS Barry","year":"2013","unstructured":"Barry DS, O\u2019Keeffe GW. Peroxisomes: the neuropathological consequences of peroxisomal dysfunction in the developing brain. Int J Biochem Cell Biol. 2013;45:2012\u20135.","journal-title":"Int J Biochem Cell Biol"},{"key":"149_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/jnr.21097","volume":"85","author":"O Krysko","year":"2007","unstructured":"Krysko O, Hulshagen L, Janssen A, Schutz G, Klein R, De Bruycker M, et al. Neocortical and cerebellar developmental abnormalities in conditions of selective elimination of peroxisomes from brain or from liver. J Neurosci Res. 2007;85:58\u201372.","journal-title":"J Neurosci Res"},{"key":"149_CR63","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/ncpgasthep1179","volume":"5","author":"SS Sundaram","year":"2008","unstructured":"Sundaram SS, Bove KE, Lovell MA, Sokol RJ. Mechanisms of disease: Inborn errors of bile acid synthesis. Nat Clin Pract Gastroenterol Hepatol. 2008;5:456\u201368.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"149_CR64","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2174\/138920012803762747","volume":"13","author":"RJ Wanders","year":"2012","unstructured":"Wanders RJ, Ferdinandusse S. Peroxisomes, peroxisomal diseases, and the hepatotoxicity induced by peroxisomal metabolites. Curr Drug Metab. 2012;13:1401\u201311.","journal-title":"Curr Drug Metab"},{"key":"149_CR65","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/pnas.0910012107","volume":"107","author":"BY Hu","year":"2010","unstructured":"Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A. 2010;107:4335\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"149_CR66","first-page":"17 6","volume":"17","author":"S Steinberg","year":"2008","unstructured":"Steinberg S, Jones R, Tiffany C, Moser A. Investigational methods for peroxisomal disorders. Curr Protoc Hum Genet. 2008;17:17 6.","journal-title":"Curr Protoc Hum Genet"},{"key":"149_CR67","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/ana.22486","volume":"70","author":"J Jang","year":"2011","unstructured":"Jang J, Kang HC, Kim HS, Kim JY, Huh YJ, Kim DS, et al. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann Neurol. 2011;70:402\u20139.","journal-title":"Ann Neurol"},{"key":"149_CR68","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1750-3639.2010.00390.x","volume":"20","author":"I Ferrer","year":"2010","unstructured":"Ferrer I, Aubourg P, Pujol A. General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol. 2010;20:817\u201330.","journal-title":"Brain Pathol"},{"key":"149_CR69","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","volume":"1822","author":"S Kemp","year":"2012","unstructured":"Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012;1822:1465\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR70","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11910-014-0486-0","volume":"14","author":"M Engelen","year":"2014","unstructured":"Engelen M, Kemp S, Poll-The BT. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol Neurosci Rep. 2014;14:486.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"149_CR71","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/emmm.201000061","volume":"2","author":"R Ofman","year":"2010","unstructured":"Ofman R, Dijkstra IM, van Roermund CW, Burger N, Turkenburg M, van Cruchten A, et al. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med. 2010;2:90\u20137.","journal-title":"EMBO Mol Med"},{"key":"149_CR72","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbalip.2014.12.005","volume":"1851","author":"MJ Schackmann","year":"2015","unstructured":"Schackmann MJ, Ofman R, Dijkstra IM, Wanders RJ, Kemp S. Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. Biochim Biophys Acta. 2015;1851:231\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR73","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1194\/jlr.M800383-JLR200","volume":"50","author":"YA Moon","year":"2009","unstructured":"Moon YA, Hammer RE, Horton JD. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J Lipid Res. 2009;50:412\u201323.","journal-title":"J Lipid Res"},{"key":"149_CR74","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/stem.404","volume":"28","author":"A Prigione","year":"2010","unstructured":"Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J. The senescence-related mitochondrial\/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells. 2010;28:721\u201333.","journal-title":"Stem Cells"},{"key":"149_CR75","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/stem.683","volume":"29","author":"A Prigione","year":"2011","unstructured":"Prigione A, Lichtner B, Kuhl H, Struys EA, Wamelink M, Lehrach H, et al. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells. 2011;29:1338\u201348.","journal-title":"Stem Cells"},{"key":"149_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cmet.2013.06.005","volume":"18","author":"X Xu","year":"2013","unstructured":"Xu X, Duan S, Yi F, Ocampo A, Liu GH, Izpisua Belmonte JC. Mitochondrial regulation in pluripotent stem cells. Cell Metab. 2013;18:325\u201332.","journal-title":"Cell Metab"},{"key":"149_CR77","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00125-012-2508-2","volume":"55","author":"J Fujikura","year":"2012","unstructured":"Fujikura J, Nakao K, Sone M, Noguchi M, Mori E, Naito M, et al. Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation. Diabetologia. 2012;55:1689\u201398.","journal-title":"Diabetologia"},{"key":"149_CR78","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/hep.20628","volume":"41","author":"R Dirkx","year":"2005","unstructured":"Dirkx R, Vanhorebeek I, Martens K, Schad A, Grabenbauer M, Fahimi D, et al. Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities. Hepatology. 2005;41:868\u201378.","journal-title":"Hepatology"},{"key":"149_CR79","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bbrc.2007.03.198","volume":"357","author":"R Dirkx","year":"2007","unstructured":"Dirkx R, Meyhi E, Asselberghs S, Reddy J, Baes M, Van Veldhoven PP. Beta-oxidation in hepatocyte cultures from mice with peroxisomal gene knockouts. Biochem Biophys Res Commun. 2007;357:718\u201323.","journal-title":"Biochem Biophys Res Commun"},{"key":"149_CR80","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/hep.21532","volume":"45","author":"MH Keane","year":"2007","unstructured":"Keane MH, Overmars H, Wikander TM, Ferdinandusse S, Duran M, Wanders RJ, et al. Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice. Hepatology. 2007;45:982\u201397.","journal-title":"Hepatology"},{"key":"149_CR81","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.freeradbiomed.2013.08.173","volume":"65","author":"B Wang","year":"2013","unstructured":"Wang B, Van Veldhoven PP, Brees C, Rubio N, Nordgren M, Apanasets O, et al. Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells. Free Radic Biol Med. 2013;65:882\u201394.","journal-title":"Free Radic Biol Med"},{"key":"149_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bbamcr.2014.11.017","volume":"1853","author":"A Peeters","year":"2015","unstructured":"Peeters A, Shinde AB, Dirkx R, Smet J, De Bock K, Espeel M, et al. Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1alpha independent proliferation. Biochim Biophys Acta. 2015;1853:285\u201398.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR83","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ceb.2009.04.005","volume":"21","author":"MA Andrade-Navarro","year":"2009","unstructured":"Andrade-Navarro MA, Sanchez-Pulido L, McBride HM. Mitochondrial vesicles: an ancient process providing new links to peroxisomes. Curr Opin Cell Biol. 2009;21:560\u20137.","journal-title":"Curr Opin Cell Biol"},{"key":"149_CR84","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fphys.2013.00268","volume":"4","author":"A Mohanty","year":"2013","unstructured":"Mohanty A, McBride HM. Emerging roles of mitochondria in the evolution, biogenesis, and function of peroxisomes. Front Physiol. 2013;4:268.","journal-title":"Front Physiol"},{"key":"149_CR85","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cub.2011.11.057","volume":"22","author":"V Soubannier","year":"2012","unstructured":"Soubannier V, McLelland GL, Zunino R, Braschi E, Rippstein P, Fon EA, et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr Biol. 2012;22:135\u201341.","journal-title":"Curr Biol"},{"key":"149_CR86","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.15252\/embj.201488104","volume":"33","author":"A Sugiura","year":"2014","unstructured":"Sugiura A, McLelland GL, Fon EA, McBride HM. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014;33:2142\u201356.","journal-title":"EMBO J"},{"key":"149_CR87","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/glia.22670","volume":"62","author":"L Morato","year":"2014","unstructured":"Morato L, Bertini E, Verrigni D, Ardissone A, Ruiz M, Ferrer I, et al. Mitochondrial dysfunction in central nervous system white matter disorders. Glia. 2014;62:1878\u201394.","journal-title":"Glia"},{"key":"149_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biochi.2013.09.012","volume":"98","author":"S Fourcade","year":"2014","unstructured":"Fourcade S, Lopez-Erauskin J, Ruiz M, Ferrer I, Pujol A. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy. Biochimie. 2014;98:143\u20139.","journal-title":"Biochimie"},{"key":"149_CR89","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1093\/hmg\/ddt186","volume":"22","author":"J Lopez-Erauskin","year":"2013","unstructured":"Lopez-Erauskin J, Galino J, Ruiz M, Cuezva JM, Fabregat I, Cacabelos D, et al. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. Hum Mol Genet. 2013;22:3296\u2013305.","journal-title":"Hum Mol Genet"},{"key":"149_CR90","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1074\/jbc.M809064200","volume":"284","author":"WJ Kovacs","year":"2009","unstructured":"Kovacs WJ, Tape KN, Shackelford JE, Wikander TM, Richards MJ, Fliesler SJ, et al. Peroxisome deficiency causes a complex phenotype because of hepatic SREBP\/Insig dysregulation associated with endoplasmic reticulum stress. J Biol Chem. 2009;284:7232\u201345.","journal-title":"J Biol Chem"},{"key":"149_CR91","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbalip.2012.02.011","volume":"1821","author":"WJ Kovacs","year":"2012","unstructured":"Kovacs WJ, Charles KN, Walter KM, Shackelford JE, Wikander TM, Richards MJ, et al. Peroxisome deficiency-induced ER stress and SREBP-2 pathway activation in the liver of newborn PEX2 knock-out mice. Biochim Biophys Acta. 2012;1821:895\u2013907.","journal-title":"Biochim Biophys Acta"},{"key":"149_CR92","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biochi.2013.10.019","volume":"98","author":"PL Faust","year":"2014","unstructured":"Faust PL, Kovacs WJ. Cholesterol biosynthesis and ER stress in peroxisome deficiency. Biochimie. 2014;98:75\u201385.","journal-title":"Biochimie"},{"key":"149_CR93","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ajmg.a.36987","volume":"167A","author":"I Fujiwara","year":"2015","unstructured":"Fujiwara I, Murakami Y, Niihori T, Kanno J, Hakoda A, Sakamoto O, et al. Mutations in PIGL in a patient with Mabry syndrome. Am J Med Genet A. 2015;167A:777\u201385.","journal-title":"Am J Med Genet A"},{"key":"149_CR94","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller JD, Ganat YM, Kishinevsky S, Bowman RL, Liu B, Tu EY, et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell. 2013;13:691\u2013705.","journal-title":"Cell Stem Cell"},{"key":"149_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/labinvest.2014.104","volume":"95","author":"KE Santostefano","year":"2015","unstructured":"Santostefano KE, Hamazaki T, Biel NM, Jin S, Umezawa A, Terada N. A practical guide to induced pluripotent stem cell research using patient samples. Lab Invest. 2015;95:4\u201313.","journal-title":"Lab Invest"},{"key":"149_CR96","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1242\/dmm.007419","volume":"4","author":"FD Mast","year":"2011","unstructured":"Mast FD, Li J, Virk MK, Hughes SC, Simmonds AJ, Rachubinski RA. A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders. Dis Model Mech. 2011;4:659\u201372.","journal-title":"Dis Model Mech"},{"key":"149_CR97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fphys.2013.00335","volume":"4","author":"PP Van Veldhoven","year":"2013","unstructured":"Van Veldhoven PP, Baes M. Peroxisome deficient invertebrate and vertebrate animal models. Front Physiol. 2013;4:335.","journal-title":"Front Physiol"},{"key":"149_CR98","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fphys.2014.00307","volume":"5","author":"Y Fujiki","year":"2014","unstructured":"Fujiki Y, Okumoto K, Mukai S, Honsho M, Tamura S. Peroxisome biogenesis in mammalian cells. Front Physiol. 2014;5:307.","journal-title":"Front Physiol"},{"key":"149_CR99","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ymgme.2014.01.008","volume":"111","author":"S Hiebler","year":"2014","unstructured":"Hiebler S, Masuda T, Hacia JG, Moser AB, Faust PL, Liu A, et al. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder. Mol Genet Metab. 2014;111:522\u201332.","journal-title":"Mol Genet Metab"},{"key":"149_CR100","doi-asserted-by":"publisher","first-page":"e100213","DOI":"10.1371\/journal.pone.0100213","volume":"9","author":"JE Faust","year":"2014","unstructured":"Faust JE, Manisundaram A, Ivanova PT, Milne SB, Summerville JB, Brown HA, et al. Peroxisomes are required for lipid metabolism and muscle function in Drosophila melanogaster. PLoS One. 2014;9:e100213.","journal-title":"PLoS One"},{"key":"149_CR101","first-page":"866","volume":"88","author":"PK Dranchak","year":"2010","unstructured":"Dranchak PK, Di Pietro E, Snowden A, Oesch N, Braverman NE, Steinberg SJ, et al. Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations. J Cel Biochem. 2010;88:866.","journal-title":"J Cel Biochem"},{"key":"149_CR102","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1750-1172-8-138","volume":"8","author":"K Berendse","year":"2013","unstructured":"Berendse K, Ebberink MS, Ijlst L, Poll-The BT, Wanders RJ, Waterham HR. Arginine improves peroxisome functioning in cells from patients with a mild peroxisome biogenesis disorder. Orphanet J Rare Dis. 2013;8:138.","journal-title":"Orphanet J Rare Dis"},{"key":"149_CR103","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1472-6793-10-19","volume":"10","author":"PA Watkins","year":"2010","unstructured":"Watkins PA, Moser AB, Toomer CB, Steinberg SJ, Moser HW, Karaman MW, et al. Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions. BMC Physiol. 2010;10:19.","journal-title":"BMC Physiol"},{"key":"149_CR104","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1476-511X-10-101","volume":"10","author":"AB Moser","year":"2011","unstructured":"Moser AB, Steinberg SJ, Watkins PA, Moser HW, Ramaswamy K, Siegmund KD, et al. Human and great ape red blood cells differ in plasmalogen levels and composition. Lipids Health Dis. 2011;10:101.","journal-title":"Lipids Health Dis"},{"key":"149_CR105","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-511X-12-10","volume":"12","author":"AB Moser","year":"2013","unstructured":"Moser AB, Hey J, Dranchak PK, Karaman MW, Zhao J, Cox LA, et al. Diverse captive non-human primates with phytanic acid-deficient diets rich in plant products have substantial phytanic acid levels in their red blood cells. Lipids Health Dis. 2013;12:10.","journal-title":"Lipids Health Dis"},{"key":"149_CR106","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1074\/jbc.R113.543652","volume":"289","author":"M Rao","year":"2014","unstructured":"Rao M, Gottesfeld JM. Introduction to thematic minireview series: Development of human therapeutics based on induced pluripotent stem cell (iPSC) technology. J Biol Chem. 2014;289:4553\u20134.","journal-title":"J Biol Chem"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-015-0149-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0149-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:14:25Z","timestamp":1718050465000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-015-0149-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,29]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1186\/s13287-015-0149-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,29]]},"assertion":[{"value":"25 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"158"}}